HC Wainwright & Co. Initiates Coverage On PaxMedica With Buy Rating, Announces Price Target of $3
BenzingaDec 4, 2023 06:45 ET
PaxMedica Analyst Ratings
BenzingaDec 4, 2023 06:44 ET
Buy Rating on PaxMedica: Strategic Value of Suramin and PRV in Neurological Disorder Treatments
TipRanksDec 4, 2023 06:19 ET
No Data
No Data